Management of multiple primary prostate malignant tumors: case report of synchronous prostatic adenocarcinoma and lymphoma.
증례보고
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: both acinar adenocarcinoma of the prostate and small lymphocytic lymphoma (SLL) invading the prostate
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
TP53 mutation may play a central role in dual clonal evolution. Multidisciplinary collaboration and individualized treatment plans are essential in managing rare presentations of prostate MPMT.
The occurrence of multiple primary prostate malignant tumors is extremely rare and there is no consensus on its diagnosis and treatment.
APA
Zhuang W, Wu H, et al. (2025). Management of multiple primary prostate malignant tumors: case report of synchronous prostatic adenocarcinoma and lymphoma.. Frontiers in oncology, 15, 1583504. https://doi.org/10.3389/fonc.2025.1583504
MLA
Zhuang W, et al.. "Management of multiple primary prostate malignant tumors: case report of synchronous prostatic adenocarcinoma and lymphoma.." Frontiers in oncology, vol. 15, 2025, pp. 1583504.
PMID
40575175
Abstract
The occurrence of multiple primary prostate malignant tumors is extremely rare and there is no consensus on its diagnosis and treatment. This article presents an elderly male patient with both acinar adenocarcinoma of the prostate and small lymphocytic lymphoma (SLL) invading the prostate. He was treated with ibrutinib for the lymphoma and goserelin and bicalutamide for the prostate cancer, resulting in control of both conditions. This case highlights the complexity of diagnosing and managing multiple synchronous prostate malignancies. TP53 mutation may play a central role in dual clonal evolution. Multidisciplinary collaboration and individualized treatment plans are essential in managing rare presentations of prostate MPMT.